undefined undefined
NaN.000
NaN.00%
HC Wainwright & Co. analyst Kevin Dede reiterates Ryvyl (NASDAQ:RVYL) with a Neutral.
05-16 00:31
H.C. Wainwright analyst Kevin Dede maintained a Hold rating on Ryvyl (RVYL – Re...
05-15 18:27
Ryvyl shares are trading lower by 30.6% during Tuesday's session. The company late Monday announced the launch of a proposed underwritten public offering, which is now cancelled.
04-17 03:06
RYVYL (NASDAQ:RVYL) announced the cancellation of the proposed underwritten public offering of shares of its common stock originally announced on April 15. The cancellation results from an assessment ...
04-16 20:41
Losers: Ryvyl (RVYL) -37% on launch of proposed underwritten public offering. MDJM Ltd (MDJH) -21%. Pacific Biosciences of California (PACB) -16% announces preliminary first Quarter 2024 revenue and u...
04-16 20:28
Gainers: GCT Semiconductor Holding (GCTS) +421%. iBio (IBIO) +198%. Cazoo Group Ltd (CZOO) +66%. Stoke Therapeutics (STOK) +44%. Lixte Biotechnology Holdings (LIXT) +44%. Ouster (OUST) +40%. Nuvation ...
03-28 01:22
12月31日,Ryvyl Inc.(RVYL.US)公布财报,公告显示公司2023财年净利润为-53.10百万美元,同比减少7.84%;其中营业收入为65.8...
03-27 22:11
Companies Reporting Before The Bell • bluebird bio (NASDAQ:BLUE) is likely to report quarterly loss at $0.66 per share on revenue of $16.68 million.
03-26 16:47
Ryvyl (NASDAQ:RVYL) is set to give its latest quarterly earnings report on Tues...
03-25 22:01
LOS ANGELES, Feb. 13, 2024 /PRNewswire/ -- The Law Offices of Frank R. Cruz is investigating potential claims against the board of directors of Ryvyl Inc. ("Ryvyl" or the "Company") (NASDAQ:...
02-14 01:00